Great article about Abivax : what makes it a unique candidate to treat Covid-19
In addition to its exciting results in ulcerative colitis
In addition to its exciting results in ulcerative colitis, Abivax's ABX 464 has shown antiviral, anti-inflammatory and tissue repair properties in COVID-19 clinical trials.
Also to be discovered
Carbios strengthens its position as a reference shareholder in its subsidiary Carbiolice
The company created by Truffle acquired Limagrain Ingredients' position in Carbiolice, thus increasing its shareholding from 52% to 70%.
Abivax Turns Away Suitors as Lead Drug Starts Covid-19 Tests
Abivax, the French biotech embarking on tests of its lead experimental medicine for Covid-19, has turned away several suitors in recent months.